PROSPR VITAL-H plans a phase 3 hybrid trial of repurposed drugs to establish a regulatory path for testing therapeutics for aging.

Provenance

First verified

2026-02-24

Last verified

2026-08-08

Version

1.0

Fingerprint

2e653dfbeaf3bb09

Change sensitivity

High

Correction state

No correction

Interpretation boundary

Primary source

https://arpa-h.gov/explore-funding/awards/4176

Related signals

• SIG-2026-007 — PROSPR VITAL-H will test repurposed drugs in a phase 3 hybrid aging trial